Continental United States with a Magnifying glass searching for Rx icon

Improved access for VYEPTI.

Your patients may already qualify. Check now.

VYEPTI Coverage Finder

Find coverage details for VYEPTI in your area.

Use the tool below to learn more about VYEPTI coverage and plan details for your patients.

Plans above are sorted in descending order by number of patients covered. This coverage tool provides medical and pharmacy benefit coverage of VYEPTI in the selected geography. It is for informational purposes only. Other options for prescription access may be available for your patients. Call VYEPTI CONNECT^® at 833-4-VYEPTI to learn more.

Results provided for informational purposes and do not guarantee coverage or payment. Benefits are determined by each plan’s administrator. Providers should consult with payers for all requirements and are responsible for the accuracy of all claims. Nothing herein may be construed as an endorsement by any plan or insurer. This resource is not a substitute for provider’s independent judgment. Lundbeck makes no claims or guarantees about the accuracy or completeness of the contents, and expressly disclaims liability for errors and omissions. Formulary status may change without notice. All trademarks belong to their respective owners. EPT-B-101479v2

IMPORTANT SAFETY INFORMATION AND INDICATION

CONTRAINDICATIONS

VYEPTI is contraindicated in patients with serious hypersensitivity to eptinezumab-jjmr or to any of the excipients. Reactions have included anaphylaxis and angioedema.

WARNINGS AND PRECAUTIONS

Hypersensitivity Reactions: Hypersensitivity reactions, including angioedema, urticaria, facial flushing, dyspnea, and rash, have occurred with VYEPTI in clinical trials and in the postmarketing setting. Most hypersensitivity reactions occurred during infusion and were not serious, but often led to discontinuation or required treatment. Serious hypersensitivity reactions may occur. Cases of anaphylaxis have been reported in the postmarketing setting. If a hypersensitivity reaction occurs, consider discontinuing VYEPTI, and institute appropriate therapy.

ADVERSE REACTIONS

The most common adverse reactions (≥2% and at least 2% or greater than placebo) in the clinical trials for the preventive treatment of migraine were nasopharyngitis and hypersensitivity.

INDICATION

VYEPTI is indicated for the preventive treatment of migraine in adults.

For more information, please see the Full Prescribing Information and Patient Information.

IMPORTANT SAFETY INFORMATION AND INDICATION

CONTRAINDICATIONS

VYEPTI is contraindicated in patients with serious hypersensitivity to eptinezumab-jjmr or to any of the excipients. Reactions have included anaphylaxis and angioedema.

WARNINGS AND PRECAUTIONS

Hypersensitivity Reactions: Hypersensitivity reactions, including angioedema, urticaria, facial flushing, dyspnea, and rash, have occurred with VYEPTI in clinical trials and in the postmarketing setting. Most hypersensitivity reactions occurred during infusion and were not serious, but often led to discontinuation or required treatment. Serious hypersensitivity reactions may occur. Cases of anaphylaxis have been reported in the postmarketing setting. If a hypersensitivity reaction occurs, consider discontinuing VYEPTI, and institute appropriate therapy.

ADVERSE REACTIONS

The most common adverse reactions (≥2% and at least 2% or greater than placebo) in the clinical trials for the preventive treatment of migraine were nasopharyngitis and hypersensitivity.

INDICATION

VYEPTI is indicated for the preventive treatment of migraine in adults.

For more information, please see the Full Prescribing Information and Patient Information.

Site map Terms of Use Privacy Policy Contact us Cookie settings

© 2024 Lundbeck. All rights reserved. VYEPTI and VYEPTI GO are registered trademarks, and VYEPTI CONNECT is a trademark of Lundbeck Seattle BioPharmaceuticals, Inc. EPT-B-101196v4

All trademarks, logos, and brand names are the property of their respective owners. All company, product, and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.

This website is intended for US healthcare professionals only.